Human platelet factor IV (PF4), a heparin-binding protein released specifically by platelets, belongs to the chemokine family and exerts multiple effects, including hematopoiesis, angiogenesis inhibition, interference with platelet coagulation, promotion of the host inflammatory response, vascular suppression, and anti-tumor properties [43]. Here, AZU1 is linked to neoplasm.